发明公开
EP1259494A1 ARYLOXYACETIC ACIDS FOR DIABETES AND LIPID DISORDERS 审中-公开
ARYLOXYESSIGSÄUREN糖尿病和血脂紊乱

  • 专利标题: ARYLOXYACETIC ACIDS FOR DIABETES AND LIPID DISORDERS
  • 专利标题(中): ARYLOXYESSIGSÄUREN糖尿病和血脂紊乱
  • 申请号: EP01910624.4
    申请日: 2001-02-14
  • 公开(公告)号: EP1259494A1
    公开(公告)日: 2002-11-27
  • 发明人: LIU, KunXU, LiboJONES, A., Brian
  • 申请人: Merck & Co., Inc.
  • 申请人地址: 126 East Lincoln Avenue Rahway,New Jersey 07065-0907 US
  • 专利权人: Merck & Co., Inc.
  • 当前专利权人: Merck & Co., Inc.
  • 当前专利权人地址: 126 East Lincoln Avenue Rahway,New Jersey 07065-0907 US
  • 代理机构: Hiscock, Ian James
  • 优先权: US183593P 20000218
  • 国际公布: WO01060807 20010823
  • 主分类号: C07D261/20
  • IPC分类号: C07D261/20 A61K31/423
ARYLOXYACETIC ACIDS FOR DIABETES AND LIPID DISORDERS
摘要:
A class of aryloxyacetic acids comprises compounds that are potent agonists of PPAR alpha and/or gamma, and are therefore useful in the treatment, control or prevention of non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, obesity, vascular restenosis, inflammation, and other PPAR alpha and/or gamma mediated diseases, disorders and conditions.
信息查询
0/0